54 related articles for article (PubMed ID: 26046410)
1. Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.
Tadmor T; Bari A; Marcheselli L; Sacchi S; Aviv A; Baldini L; Gobbi PG; Pozzi S; Ferri P; Cox MC; Cascavilla N; Iannitto E; Federico M; Polliack A
Mayo Clin Proc; 2015 Jun; 90(6):756-64. PubMed ID: 26046410
[TBL] [Abstract][Full Text] [Related]
2. Platelet-to-lymphocyte ratio and absolute monocyte count have prognostic potential in primary myelodysplastic neoplasms.
Qu H; Chu J; Wang L; Zhang J; Han J; Li Z; Hou H; Wang Y; Liu Y; Wu H
Int J Lab Hematol; 2024 Apr; 46(2):275-285. PubMed ID: 38105483
[TBL] [Abstract][Full Text] [Related]
3. The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
Rodday AM; Parsons SK; Upshaw JN; Friedberg JW; Gallamini A; Hawkes E; Hodgson D; Johnson P; Link BK; Mou E; Savage KJ; Zinzani PL; Maurer M; Evens AM
J Clin Oncol; 2023 Apr; 41(11):2076-2086. PubMed ID: 36495588
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.
Ho CL; Lu CS; Chen JH; Chen YG; Huang TC; Wu YY
Medicine (Baltimore); 2015 Jun; 94(24):e993. PubMed ID: 26091479
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
Marcheselli R; Bari A; Tadmor T; Marcheselli L; Cox MC; Pozzi S; Ferrari A; Baldini L; Gobbi P; Aviv A; Pugliese G; Federico M; Polliack A; Sacchi S
Hematol Oncol; 2017 Dec; 35(4):561-566. PubMed ID: 27791277
[TBL] [Abstract][Full Text] [Related]
6. Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: A Haematologist's Perspective.
Follows GA
Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):457-9. PubMed ID: 26071896
[No Abstract] [Full Text] [Related]
7. Disparities in survival by insurance status in patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Green BL; Harrison LB; Yahalom J
Cancer; 2015 Oct; 121(19):3515-24. PubMed ID: 26058564
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.
Reddy JP; Hernandez M; Gunther JR; Dabaja BS; Martin GV; Jiang W; Akhtari M; Allen PK; Atkinson BJ; Smith GL; Pinnix CC; Milgrom SA; Abou Yehia Z; Osborne EM; Oki Y; Lee H; Hagemeister F; Fanale MA
Br J Haematol; 2018 Feb; 180(4):545-549. PubMed ID: 29271057
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?
Goze H; Cinli TA; Baydilli KN; Serin I
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):14-32. PubMed ID: 38680717
[No Abstract] [Full Text] [Related]
10. Monocyte programming by cancer therapy.
Patysheva M; Frolova A; Larionova I; Afanas'ev S; Tarasova A; Cherdyntseva N; Kzhyshkowska J
Front Immunol; 2022; 13():994319. PubMed ID: 36341366
[TBL] [Abstract][Full Text] [Related]
11. The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma.
Zhang Y; Shi Y; Shen H; Shou L; Fang Q; Zheng X; Zhu M; Huang X; Huang J; Li L; Zhou D; Zhu L; Zhu J; Ye X; Jin J; Xie W
Cancer Cell Int; 2021 Oct; 21(1):573. PubMed ID: 34715862
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.
Gebauer N; Mengler B; Kopelke S; Frydrychowicz A; Fürschke A; Hackenbroch C; Bauer A; Riecke A; von Bubnoff N; Fetscher S; Witte HM
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1789-1801. PubMed ID: 34415426
[TBL] [Abstract][Full Text] [Related]
13. Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies.
Kawashima M; Higuchi H; Kotani A
J Clin Exp Hematop; 2021 Dec; 61(4):192-201. PubMed ID: 34193756
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma.
Gao F; Hu J; Zhang J; Xu Y
J Cancer; 2021; 12(12):3407-3417. PubMed ID: 33995619
[No Abstract] [Full Text] [Related]
15. Broadening our understanding of genetic risk for scleroderma/systemic sclerosis by querying the chromatin architecture surrounding the risk haplotypes.
Poppenberg KE; Tutino VM; Tarbell E; Jarvis JN
BMC Med Genomics; 2021 Apr; 14(1):114. PubMed ID: 33894768
[TBL] [Abstract][Full Text] [Related]
16. The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients.
Shen QQ; Gao J; Tao H; Wang ST; Wang FJ; Chen YY; Zhang X; Jia YQ
Am J Blood Res; 2021; 11(1):100-110. PubMed ID: 33796397
[TBL] [Abstract][Full Text] [Related]
17. Circulating Myeloid Regulatory Cells: Promising Biomarkers in B-Cell Lymphomas.
Ferrant J; Lhomme F; Le Gallou S; Irish JM; Roussel M
Front Immunol; 2020; 11():623993. PubMed ID: 33603754
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymphocyte-to-monocyte ratio and histone methyltransferase G9a histone methyltransferase in patients with double expression lymphoma: A retrospective observational study.
Xu P; Sun X; Song X; Peng Y; He B; Wu Z; Zhu J
Medicine (Baltimore); 2021 Jan; 100(4):e24449. PubMed ID: 33530253
[TBL] [Abstract][Full Text] [Related]
19. The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial.
Romano A; Pavoni C; Di Raimondo F; Tarella C; Viviani S; Rossi A; Patti C; Picardi M; Cantonetti M; La Nasa G; Trentin L; Bolis S; Zoli V; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis G; Zanotti R; Gini G; Ferreri AJM; Viero P; Chauvie S; Biggi A; Massimo Gianni A; Gallamini A; Rambaldi A
Cancer Med; 2020 Dec; 9(23):8735-8746. PubMed ID: 33155754
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression.
Asai A; Yasuoka H; Matsui M; Tsuchimoto Y; Fukunishi S; Higuchi K
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
